Contact this trialFirst, we need to learn more about you.
Janus Kinase (JAK) Inhibitor
Topical Ruxolitinib Cream for Hidradenitis Suppurativa
Recruiting1 awardPhase 2
Hershey, Pennsylvania
This trial is testing whether a cream containing the drug ruxolitinib can reduce disease activity in people with HS. Investigators will also study how this drug affects inflammation by looking at skin biopsy samples.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service